Clinical Trial Update: Off-the-shelf CD123 CAR-NK for R/R AML [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 trial evaluating off-the-shelf CD123 CAR-NK cells for relapsed or refractory acute myeloid leukemia; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CD123 CAR-NK cells (off-the-shelf)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory | EARLY_Phase 1 | Status: RECRUITING